1 completed, 1 not yet recruiting. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Non-small Cell Lung Cancer (NSCLC) Stage IV: new trials by email Literature Review of Non-small Cell Lung Cancer (NSCLC) Stage IV trials Research Report on Non-small Cell Lung Cancer (NSCLC) Stage IV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung Cancer Benmelstobart Combined With Anlotinib - Non-small Cell Lung Cancer (NSCLC) Stage IV, Locally Advanced Non-Small Cell Lung Cancer | Not applicable | Not yet recruiting | Zhejiang Cancer Hospital | 30 | 2026-10-01 | 2026-09-30 |
| A Study to Evaluate the Safety and Efficacy of Ex Vivo Expanded Autologous Immune Killer Cells (IKC) in Stage IV Non-small Cell Lung Cancer (NSCLC) in Patients Who Failed Chemotherapy or Target Therapy Immune Killer Cells (IKC) - Non-small Cell Lung Cancer (NSCLC) Stage IV | Phase 2 | Completed | Ivy Life Sciences, Co., Ltd | 26 | 2017-12-05 | 2020-04-16 |
Carcinoma, Non-Small-Cell Lung (2)
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Diseases (2) · Lung Neoplasms (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2)
anlotinib (1)
Ivy Life Sciences, Co., Ltd (1) · Zhejiang Cancer Hospital (1)
China (1) · Taiwan (1)